The Details...
Reporting to the Associate Director, Regional Sales, the Strategic Account Manager will own territory strategy and execution across New South Wales, the Australian Capital Territory and New Zealand to grow revenue and expand Oxford Nanopore’s footprint across research, clinical and applied customers. You will build and manage top‑tier relationships and KOL engagement, identify new market opportunities, and convert complex sales by coordinating cross‑functional resources. To achieve the objectives of this role, you will be expected to travel up to 50% of the time.
Other responsibilities include:
- Develop and implement a territory strategic business plan aligned with regional targets
- Manage and grow relationships with senior decision makers and key opinion leaders across multiple disciplines
- Identify and qualify new opportunities and adjacent markets within the territory
- Navigate funding cycles and procurement/decision‑making processes to accelerate sales
- Delivering to the agreed targets for Oxford Nanopore Technologies
- Adhering to best practices for tracking, recording and documenting relevant commercial intelligence from all customer interactions
What We're Looking For:
- BSc in Life Sciences or related discipline; advanced degree advantageous. Proven field commercial experience selling complex scientific products or services, ideally into research and clinical environments
- Strong track record of strategic account management, KOL engagement and territory growth
- Excellent presentation, negotiation and stakeholder‑management skills
- Commercially astute with experience working to budgets and structured sales processes
- Confident using CRM systems to manage pipeline and record commercial intelligence
- Outstanding organisation, time management and the ability to work autonomously under pressure in a matrixed environment
- Willingness and ability to travel up to 50%
What will make you stand out:
- Experience disrupting established technologies or driving adoption of new platforms
- Existing contacts and credibility within academic research, core facilities or clinical labs
- Experience working with multi‑disciplinary and international stakeholders
Why join:
- Work with cutting-edge sequencing technology in a fast-growing, disruptive company
- Collaborative global teams and strong technical support to help close and deliver deals
- Opportunity to shape territory strategy and make visible impact on company growth
No terminology in this advert is intended to discriminate on any protected ground. Candidates will be assessed only on their merits, qualifications and ability to perform the role.
How to apply
Submit your CV and a brief cover note outlining your relevant territory or strategic account experience and examples of sales wins. Applications will be reviewed as they are received.
#LI-MW1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Skills Required
- BSc in Life Sciences or related discipline; advanced degree advantageous
- Proven field commercial experience selling complex scientific products or services
- Strong track record of strategic account management and KOL engagement
- Excellent presentation, negotiation and stakeholder-management skills
- Experience working to budgets and structured sales processes
- Confident using CRM systems to manage pipeline
- Outstanding organisation, time management and autonomy
- Willingness to travel up to 50%
Oxford Nanopore Technologies Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Oxford Nanopore Technologies and has not been reviewed or approved by Oxford Nanopore Technologies.
-
Fair & Transparent Compensation — Pay is considered good to above average across many roles, with employer-provided ranges visible for several U.S. commercial and applications positions and company materials emphasizing market‑competitive base pay. Commercial and some senior technical posts, particularly in the U.S., are positioned as competitive and often paired with strong variable components.
-
Equity Value & Accessibility — All‑employee share plans in the UK and a U.S. employee stock purchase plan indicate broad access to equity as part of total reward. Company communications highlight attractive bonus and share plans that add meaningful upside beyond base pay.
-
Healthcare Strength — U.S. roles indicate strong health insurance and core protections, while official materials and country overviews reference private medical coverage and wellbeing support. These elements position the health package as a notable strength alongside cash compensation.
Oxford Nanopore Technologies Insights
What We Do
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
